Acknowledgement
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (MSIT; NRF-2017M3A 9B5060880). In addition, the authors were supported by Chungnam National University and the Korea Research Institute of Bioscience and Biotechnology (KRIBB).
References
- Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003;2:205-213. https://doi.org/10.1038/nrd1031
- Friedman ZY. Recent advances in understanding the molecular mechanisms of tamoxifen action. Cancer Invest 1998;16:391-396. https://doi.org/10.3109/07357909809115779
- Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M, et al. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat Rev 2013;39:935-946. https://doi.org/10.1016/j.ctrv.2013.03.009
- Osborne CK, Boldt DH, Clark GM, Trent JM. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 1983;43:3583-3585.
- Baral E, Nagy E, Berczi I. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol. Cancer 1995;75:591-599. https://doi.org/10.1002/1097-0142(19950115)75:2<591::AID-CNCR2820750224>3.0.CO;2-U
- Khan SZ, Longland CL, Michelangeli F. The effects of phenothiazines and other calmodulin antagonists on the sarcoplasmic and endoplasmic reticulum Ca(2+) pumps. Biochem Pharmacol 2000;60:1797-1806. https://doi.org/10.1016/S0006-2952(00)00505-0
- Wiseman H, Cannon M, Arnstein HR, Halliwell B. Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifen. Biochim Biophys Acta 1993;1181:201-206. https://doi.org/10.1016/0925-4439(93)90021-R
- Wagner EM, Gallagher SJ, Reddy S, Mitzner W. Effects of tamoxifen on ischemia-induced angiogenesis in the mouse lung. Angiogenesis 2003;6:65-71. https://doi.org/10.1023/A:1025822127847
- Altan N, Chen Y, Schindler M, Simon SM. Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc Natl Acad Sci U S A 1999;96:4432-4437. https://doi.org/10.1073/pnas.96.8.4432
- Gundimeda U, Chen ZH, Gopalakrishna R. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J Biol Chem 1996;271:13504-13514. https://doi.org/10.1074/jbc.271.23.13504
- Chang Y, Lee JJ, Chen WF, Chou DS, Huang SY, Sheu JR. A novel role for tamoxifen in the inhibition of human platelets. Transl Res 2011;157:81-91. https://doi.org/10.1016/j.trsl.2010.10.004
- Chen IC, Hsiao LP, Huang IW, Yu HC, Yeh LC, Lin CH, et al. Phosphatidylinositol-3 kinase inhibitors, buparlisib and alpelisib, sensitize estrogen receptor-positive breast cancer cells to tamoxifen. Sci Rep 2017;7:9842. https://doi.org/10.1038/s41598-017-10555-z
- Chen Y, Schindler M, Simon SM. A mechanism for tamoxifen-mediated inhibition of acidification. J Biol Chem 1999;274:18364-18373. https://doi.org/10.1074/jbc.274.26.18364
- Hasegawa G, Akatsuka K, Nakashima Y, Yokoe Y, Higo N, Shimonaka M. Tamoxifen inhibits the proliferation of nonmelanoma skin cancer cells by increasing intracellular calcium concentration. Int J Oncol 2018;53:2157-2166.
- de Medina P, Favre G, Poirot M. Multiple targeting by the antitumor drug tamoxifen: a structure-activity study. Curr Med Chem Anticancer Agents 2004;4:491-508. https://doi.org/10.2174/1568011043352696
- Dolan K, Montgomery S, Buchheit B, Didone L, Wellington M, Krysan DJ. Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization. Antimicrob Agents Chemother 2009;53:3337-3346. https://doi.org/10.1128/AAC.01564-08
- Beggs WH. Anti-Candida activity of the anti-cancer drug tamoxifen. Res Commun Chem Pathol Pharmacol 1993;80:125-128.
- Lum PY, Armour CD, Stepaniants SB, Cavet G, Wolf MK, Butler JS, et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004;116:121-137. https://doi.org/10.1016/S0092-8674(03)01035-3
- Wiseman H, Cannon M, Arnstein HR. Observation and significance of growth inhibition of Saccharomyces cerevisiae (A224A) by the anti-oestrogen drug tamoxifen. Biochem Soc Trans 1989;17:1038-1039. https://doi.org/10.1042/bst0171038
- Nguyen Hoang AT, Hoe KL, Lee SJ. CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells. PLoS One 2021;16:e0246264. https://doi.org/10.1371/journal.pone.0246264
- Nurse P. Fission yeast cell cycle mutants and the logic of eukaryotic cell cycle control. Mol Biol Cell 2020;31:2871-2873. https://doi.org/10.1091/mbc.E20-10-0623
- Han S, Lee M, Chang H, Nam M, Park HO, Kwak YS, et al. Construction of the first compendium of chemical-genetic profiles in the fission yeast Schizosaccharomyces pombe and comparative compendium approach. Biochem Biophys Res Commun 2013;436:613-618. https://doi.org/10.1016/j.bbrc.2013.05.138
- Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999;285:901-906. https://doi.org/10.1126/science.285.5429.901
- Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, Porter J, et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 2006;126:611-625. https://doi.org/10.1016/j.cell.2006.06.040
- Iorns E, Lord CJ, Ashworth A. Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. Biochem J 2009;417:361-370. https://doi.org/10.1042/BJ20081682
- Mendes-Pereira AM, Sims D, Dexter T, Fenwick K, Assiotis I, Kozarewa I, et al. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen. Proc Natl Acad Sci U S A 2012;109:2730-2735. https://doi.org/10.1073/pnas.1018872108
- Kim DU, Hayles J, Kim D, Wood V, Park HO, Won M, et al. Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat Biotechnol 2010;28:617-623. https://doi.org/10.1038/nbt.1628
- Kume K, Hashimoto T, Suzuki M, Mizunuma M, Toda T, Hirata D. Identification of three signaling molecules required for calcineurin-dependent monopolar growth induced by the DNA replication checkpoint in fission yeast. Biochem Biophys Res Commun 2017;491:883-889. https://doi.org/10.1016/j.bbrc.2017.07.129
- Chesnel F, Couturier A, Alusse A, Gagne JP, Poirier GG, Jean D, et al. The prefoldin complex stabilizes the von Hippel-Lindau protein against aggregation and degradation. PLoS Genet 2020;16:e1009183. https://doi.org/10.1371/journal.pgen.1009183
- Haridas V. Tailoring of peptide vesicles: a bottom-up chemical approach. Acc Chem Res 2021;54:1934-1949. https://doi.org/10.1021/acs.accounts.0c00690
- Takegawa K, Iwaki T, Fujita Y, Morita T, Hosomi A, Tanaka N. Vesicle-mediated protein transport pathways to the vacuole in Schizosaccharomyces pombe. Cell Struct Funct 2003;28:399-417. https://doi.org/10.1247/csf.28.399
- Taleat Z, Larsson A, Ewing AG. Anticancer drug tamoxifen affects catecholamine transmitter release and storage from single cells. ACS Chem Neurosci 2019;10:2060-2069. https://doi.org/10.1021/acschemneuro.8b00714
- Wang CW, Klionsky DJ. The molecular mechanism of autophagy. Mol Med 2003;9:65-76. https://doi.org/10.1007/bf03402040